Low dose linomide in Type I juvenile diabetes of recent onset: a randomised placebo-controlled double blind trial
R. Coutant(Centre Hospitalier Universitaire d'Angers), Pierre Bougnères(Hôpital Saint-Vincent-de-Paul), Christin Johnsen(University of Washington), Paul Landais(Hôpital Necker-Enfants Malades), Myriam Rosilio(Hôpital Saint-Vincent-de-Paul), N. Lahlou(Hôpital Saint-Vincent-de-Paul), Johnny Ludvigsson(Linköping University), Jean‐Claude Carel(Inserm), Pierre Chatelain(Hôpital Edouard Herriot), Christian Boîtard(Hôpital Saint-Vincent-de-Paul)
Cited by 83
Related Papers
A mutation in the human leptin receptor gene causes obesity and pituitary dysfunction
|Nature|1998|2.4k
Hematopoietic Stem Cell Gene Therapy with a Lentiviral Vector in X-Linked Adrenoleukodystrophy
|Science|2009|1.5k
Consensus Statement on the Use of Gonadotropin-Releasing Hormone Analogs in Children
|PEDIATRICS|2009|797
Child Health, Developmental Plasticity, and Epigenetic Programming
|Endocrine Reviews|2010|625
Causes, diagnosis, and treatment of central precocious puberty
|The Lancet Diabetes & Endocrinology|2016|509